263 related articles for article (PubMed ID: 25525048)
1. Laboratory assessment of the anticoagulant activity of dabigatran.
Kyriakou E; Ikonomidis I; Stylos D; Bonovas S; Papadakis I; Nikolopoulos GK; Kokoris S; Kalantzis D; Economopoulou C; Kopterides P; Lekakis J; Tsantes AE
Clin Appl Thromb Hemost; 2015 Jul; 21(5):434-45. PubMed ID: 25525048
[TBL] [Abstract][Full Text] [Related]
2. Impact of dabigatran on platelet function and fibrinolysis.
Tsantes AE; Kyriakou E; Bonovas S; Chondrogianni M; Zompola C; Liantinioti C; Simitsi A; Katsanos AH; Atta M; Ikonomidis I; Kapsimali V; Kopterides P; Tsivgoulis G
J Neurol Sci; 2015 Oct; 357(1-2):204-8. PubMed ID: 26219486
[TBL] [Abstract][Full Text] [Related]
3. Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study.
Tsantes AE; Kyriakou E; Ikonomidis I; Katogiannis K; Papadakis I; Douramani P; Kopterides P; Kapsimali V; Lekakis J; Tsangaris I; Bonovas S
Medicine (Baltimore); 2016 Apr; 95(14):e3037. PubMed ID: 27057830
[TBL] [Abstract][Full Text] [Related]
4. The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate.
Chang YT; Hu YF; Liao JN; Chern CM; Lin YJ; Chang SL; Wu CH; Sung SH; Wang KL; Lu TM; Chao TF; Lo LW; Hsu LC; Chung CP; Chang PM; Hsu WH; Chiou CW; Chen SA
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):389-95. PubMed ID: 26991859
[TBL] [Abstract][Full Text] [Related]
5. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG
Solbeck S; Jensen AS; Maschmann C; Stensballe J; Ostrowski SR; Johansson PI
Scand J Clin Lab Invest; 2018; 78(1-2):25-30. PubMed ID: 29304563
[TBL] [Abstract][Full Text] [Related]
6. [Monitoring of Oral Thrombin Inhibitor].
Matsuno K; Usami T; Hatuse M; Shimizu C
Rinsho Byori; 2014 Oct; 62(10):958-64. PubMed ID: 27526541
[TBL] [Abstract][Full Text] [Related]
7. A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.
Wang H; Zhou Y; Rong G; Lu L; Zhang J
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):563-7. PubMed ID: 26881855
[TBL] [Abstract][Full Text] [Related]
8. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
Helin TA; Lemponen M; Hjemdahl P; Rönquist-Nii Y; Lassila R; Joutsi-Korhonen L
Thromb Res; 2015 Jul; 136(1):154-60. PubMed ID: 25981140
[TBL] [Abstract][Full Text] [Related]
9. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
Honickel M; Treutler S; van Ryn J; Tillmann S; Rossaint R; Grottke O
Thromb Haemost; 2015 Apr; 113(4):728-40. PubMed ID: 25567155
[TBL] [Abstract][Full Text] [Related]
10. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
Taune V; Wallén H; Ågren A; Gryfelt G; Sjövik C; Wintler AM; Malmström RE; Wikman A; Skeppholm M
Thromb Res; 2017 May; 153():76-82. PubMed ID: 28347811
[TBL] [Abstract][Full Text] [Related]
11. The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma.
Zhang C; Zhang P; Li H; Han L; Zhang L; Zhang L; Yang X
Thromb Res; 2018 May; 165():38-43. PubMed ID: 29558660
[TBL] [Abstract][Full Text] [Related]
12. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
Sokol J; Nehaj F; Ivankova J; Mokan M; Zolkova J; Lisa L; Linekova L; Mokan M; Stasko J
Clin Appl Thromb Hemost; 2021; 27():1076029620983902. PubMed ID: 33523711
[TBL] [Abstract][Full Text] [Related]
13. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
Douxfils J; Lessire S; Dincq AS; Hjemdahl P; Rönquist-Nii Y; Pohanka A; Gourdin M; Chatelain B; Dogné JM; Mullier F
Thromb Haemost; 2015 Apr; 113(4):862-9. PubMed ID: 25519251
[TBL] [Abstract][Full Text] [Related]
14. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
Green L; Lawrie AS; Patel R; Stephens RC; Mackie IJ; Chitolie A; Haddad FS; Machin SJ
Thromb Res; 2012 Nov; 130(5):775-9. PubMed ID: 22245224
[TBL] [Abstract][Full Text] [Related]
15. The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency.
Gribkova IV; Lipets EN; Rekhtina IG; Bernakevich AI; Ayusheev DB; Ovsepyan RA; Ataullakhanov FI; Sinauridze EI
Sci Rep; 2016 Jul; 6():29242. PubMed ID: 27377013
[TBL] [Abstract][Full Text] [Related]
16. Dabigatran: is there a role for coagulation assays in guiding therapy?
Brunetti L; Bandali F
Ann Pharmacother; 2013 Jun; 47(6):828-40. PubMed ID: 23673530
[TBL] [Abstract][Full Text] [Related]
17. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
[TBL] [Abstract][Full Text] [Related]
18. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
[TBL] [Abstract][Full Text] [Related]
19. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
Taune V; Skeppholm M; Ågren A; Gryfelt G; Malmström RE; Wikman A; Van Ryn J; Wallén H
J Thromb Haemost; 2018 Dec; 16(12):2462-2470. PubMed ID: 30288934
[TBL] [Abstract][Full Text] [Related]
20. Assessing the anticoagulant effect of dabigatran in children: an in vitro study.
Dietrich K; Stang L; van Ryn J; Mitchell LG
Thromb Res; 2015 Apr; 135(4):630-5. PubMed ID: 25715905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
